Applicant, as named in the Orange Book
Lenz Therap
Next listed expiry: Vizz on 15 Mar 2044. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Vizz NDA 218585 aceclidine hydrochloride | 15 Mar 2044 patent, carve-out possible |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.